Category: oncology retractions

Anticancer-fungus paper retracted because some of the results “may be inaccurate”

biomacroMaybe it was a case of hitting the “send” button a bit too soon, or maybe it was a spasm of seller’s remorse, but a group of Chinese researchers has retracted a paper they’d published preliminarily a few months earlier.

The paper, “Antitumor and immunomodulatory activity of a polysaccharide from fungus Coprinus comatus (Mull.:Fr.) Gray,” by a group from various institutions in Shaanxi, appeared in April on the website of International Journal of Biological Macromolecules (as what appears to have been an uncorrected proof). But that didn’t stick.

According to a retraction notice dated August 2nd: Continue reading Anticancer-fungus paper retracted because some of the results “may be inaccurate”

Retraction notice for cancer paper gives wide berth to the “p” word

jneuroncolThe Journal of Neuro-Oncology has retracted a 2009 article on brain tumors for what’s clearly plagiarism — but which is called everything but.

The article was titled “Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging,” and it came from a group at the Sree Chitra Tirunal Institute for Medical Sciences and Technology, in Trivandrum, India.

Here’s the — rather laughable — retraction notice, which dances around the matter about as deftly as a freshman with the prom queen:

Continue reading Retraction notice for cancer paper gives wide berth to the “p” word

Paper on rare pediatric lung cancer retracted for misstatements, unknowing authors

logo-journalecancermedicalscience (officially in the running for the most cumbersome journal title we’ve run across) has retracted a 2013 case report for a litany of sins.

The article, “Primary extraosseous Ewing sarcoma of the lung in children,” came from a group in France: Nidal Alsit, Clara Fernandez, Jean Luc Michel , Linda Sakhri, Audrey Derouet and Augustin Pirvu.

Or at least that’s what the author information suggested. Continue reading Paper on rare pediatric lung cancer retracted for misstatements, unknowing authors

Paper on vulvar tumor retracted. Why? Journal won’t say

JLGTCancer of the vulva may well be a topic most people do not want to discuss. But we wish the Journal of Lower Genital Tract Disease (the official journal of several societies, including the American Society for Colposcopy and Cervical Pathology, the Australian Society for Colposcopy and Cervical Pathology and the Society of Canadian Colposcopists) had been a bit more forthcoming about its retraction of a 2013 paper on the subject.

The article, “Granular Cell Tumor of the Vulva,” appeared in the January issue of the journal from a group whose last last author was Sofia Vázquez Navarrete, a pathologist at La Línea de la Concepción, in Cádiz, Spain.

Its abstract stated: Continue reading Paper on vulvar tumor retracted. Why? Journal won’t say

Lacking “scientific and analytical rigor,” 8-year-old lymphoma paper falls to retraction

leuklympjuly13Leukemia & Lymphoma has retracted 2004 paper by a group of authors in Mexico after concluding that, well, the article never should have been accepted to begin with.

The article, “Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome,” came from oncologists at the National Medical Center. Its abstract (still available on Medline) states: Continue reading Lacking “scientific and analytical rigor,” 8-year-old lymphoma paper falls to retraction

21-year-old article on the sex lives of women with cancer retracted for data misuse

journal of sex researchHere’s one for the way-back machine.

The Annual Review of Sex Research (which is a supplement to the Journal of Sex Research) has retracted a 1992 paper by a group of researchers who lifted much of their analysis from two even older articles by another scholar. At 21 years post-publication, this is one of the oldest — but not the record-oldest — retractions we’ve covered to date.

The pulled paper, “Sexuality and cancer in women,” came from Willibrord C. M. Weijmar Schultz, Harry B. M. Van de Wiel, Daniela E. E. Hahn, and Mels F. Van Driel. (Weijmar Schultz and Van de Wiel  are co-authors of this rather curious passage about the appropriateness of sexual contact between doctors and patients:

Continue reading 21-year-old article on the sex lives of women with cancer retracted for data misuse

A fifth retraction for former Pitt and Hopkins oncology researcher Getzenberg

ccrA cancer researcher whose work was the subject of a lawsuit has retracted his fifth paper, this one from 2004.

Robert Getzenberg, formerly of the University of Pittsburgh and Johns Hopkins, has had two papers on prostate cancer biomarkers retracted, and two on colon cancer. The newly retracted paper is about a potential bladder cancer biomarker.

Here’s the notice from Clinical Cancer Research: Continue reading A fifth retraction for former Pitt and Hopkins oncology researcher Getzenberg

A double-bill from Digestive Diseases and Sciences, both for regurgitation — aka duplication

ddsComing back up?

Digestive Diseases and Sciences has retracted two papers for duplication.

The first paper, “Membrane-Bound Mucins and Mucin Terminal Glycans Expression in Idiopathic or Helicobacter pylori, NSAID Associated Peptic Ulcers,” was published in October 2012 by a group from Israel and the United States. It found that:

Cytoplasmic MUC17 staining was significantly decreased in the cases with idiopathic ulcer. The opposite was demonstrated for MUC1. This observation might be important, since different mucins with altered sialylation patterns likely differ in their protection efficiency against acid and pepsin.

But, as the retraction notice suggests, that much had been found before: Continue reading A double-bill from Digestive Diseases and Sciences, both for regurgitation — aka duplication

Authors hit for image manipulation cycle, but don’t worry, they’ll resubmit retracted paper

j virologyRegrets were had, mistakes were made, but gosh-darn-it, they’re gonna resubmit that retracted paper in the future.

Such is the message from a retraction of “Tsg101 Interacts with Herpes Simplex Virus 1 VP1/2 and Is a Substrate of VP1/2 Ubiquitin-Specific Protease Domain Activity,” from Italian virologists who admitted to copying and pasting their way into the Journal of Virology: Continue reading Authors hit for image manipulation cycle, but don’t worry, they’ll resubmit retracted paper

Dodgy figure in cord blood paper prompts Expression of Concern in oncology journal

cmionccoverThe editor of Clinical Medicine Insights: Oncology has issued an Expression of Concern over a 2008 paper by a group of authors in China after identifying “flaws” in one of the figures.

The article, “Exvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cells derived from umbilical cord blood for immunotherapy treatment,” purported to show that:

tumor-specific antigens present on exosomes can be presented by DCs [dendritic cells] derived from unrelated umbilical cord blood to induce tumor specific cytotoxicity and this may represent as a novel immunotherapy for ovarian cancer.

But according to William C. S. Cho, editor of the journal, there’s reason to doubt the conclusions. As the notice explains:
Continue reading Dodgy figure in cord blood paper prompts Expression of Concern in oncology journal